Ferozsons Laboratories Limited (PSX:FEROZ)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
378.85
+3.54 (0.94%)
At close: Dec 5, 2025
-0.30%
Market Cap 16.47B
Revenue (ttm) 20.27B
Net Income (ttm) 814.84M
Shares Out 43.47M
EPS (ttm) 18.74
PE Ratio 20.21
Forward PE n/a
Dividend 4.00 (1.07%)
Ex-Dividend Date Oct 16, 2025
Volume 20,849
Average Volume 43,844
Open 380.00
Previous Close 375.31
Day's Range 368.10 - 380.00
52-Week Range 242.33 - 464.00
Beta 0.37
RSI 38.39
Earnings Date Feb 16, 2026

About Ferozsons Laboratories

Ferozsons Laboratories Limited, together with its subsidiaries, engages in the importing, manufacturing, and sale of pharmaceutical products and medical devices in Pakistan, Afghanistan, Sri Lanka, the Philippines, Kenya, Myanmar, Kyrgyzstan, Mongolia, Cambodia, and internationally. The company offers products in various therapeutic areas of anti-fungal, anti-viral, antibiotics, cardiometabolic, cough, dermatology, diabetes, gastrointestinal and liver, oncology, orthopedic, and urology and nephrology areas. It also provides medical devices in t... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1954
Employees 1,556
Stock Exchange Pakistan Stock Exchange
Ticker Symbol FEROZ
Full Company Profile

Financial Performance

In 2025, Ferozsons Laboratories's revenue was 18.86 billion, an increase of 18.94% compared to the previous year's 15.85 billion. Earnings were 776.54 million, an increase of 13.67%.

Financial Statements

News

There is no news available yet.